CRT exclusive agreement: Vertebrate Antibodies Ltd reached an agreement with Cancer Research Technology (CRT) to exclusively license a number of their monoclonal antibodies for Research Only. The antibodies are specific towards the following human targets; BCLAF1, CCT2, CYP1A2, CYP1A, CYP2A6, CYP2E1, CYP2R1, CYP4F11, CYP4A11, CYP4V2, CYP4Z1, CYP3A4, CYP3A5, [...]
SMART-SCOTLAND feasibility study award “Discovery of colorectal cancer biomarkers and validation of antibodies towards them for use as diagnostic or therapeutic agents”. Over the duration of 18 months and in collaboration with Professor Graeme Murray at Aberdeen University, the projects aims to deliver a portfolio of novel tumour [...]
Knowledge Transfer and Exchange Award in collaboration with Dr Jun Zou at the Scottish Fish Immunology Research Centre (SFIRC). The award aimed at developing assays to monitor vaccine performance in salmonids. Outcome: monoclonal antibodies are developed to key cytokines i.e. INFg. Quantitative and qualitative assays are being optimised [...]
Kick Start award in collaboration with Professor Graeme Murray, University of Aberdeen, with focus on the discovery of colorectal cancer biomarkers and the validation of antibodies towards them for use as prognostic agents. Outcome: The project targeted retinoic acid metabolising enzymes. Retinoic acid is a metabolite of vitamin [...]